1. |
Hooijmans CR, Rovers MM, de Vries RB, et al. SYRCLE's risk of bias tool for animal studies. BMC Med Res Methodol, 2014, 14: 43.
|
2. |
Sandercock P, Roberts I. Systematic reviews of animal experiments. Lancet, 2002, 360(9333): 586.
|
3. |
贺争鸣, 邢瑞昌, 方喜业, 等. 论实验动物福利、动物实验与动物实验替代方法. 实验动物科学与管理, 2005, 22(1): 61-64.
|
4. |
Kilkenny C, Parsons N, Kadyszewski E, et al. Survey of the quality of experimental design, statistical analysis and reporting of research using animals. PLoS One, 2009, 4(11): e7824.
|
5. |
Krauth D, Woodruff TJ, Bero L. Instruments for assessing risk of bias and other methodological criteria of published animal studies: a systematic review. Environ Health Perspect, 2013, 121(9): 985-992.
|
6. |
双梅, 赵晨, 张莉, 等. 运用 SYRCLE 工具评价中文期刊发表卒中/中风动物实验的方法学质量. 中国循证医学杂志, 2016, 16(5): 592-597.
|
7. |
陈匡阳, 马彬, 王亚楠, 等. SYRCLE 动物实验偏倚风险评估工具简介. 中国循证医学杂志, 2014, 14(10): 1281-1285.
|
8. |
Higgins J, Green S. Cochrane handbook for systematic reviews of interventions: version 5.1.0. London: The Cochrane Collaboration, 2011. Avialble at: www.handbook.cochrane.org.
|
9. |
Johnston NA, Nevalainen T. Impact of biotic and abiotic environmenton animal experiments. Edited by Hau JS. In handbook of laboratory animal science (Book 1). The 3rd edition. Florida: CRC Press, 2010: 343-369.
|
10. |
Donnelly H, Saibaba P. Light intensity and the oestrous cycle in albino and normally pigmented mice. Lab Anim, 1993, 27(4): 385-390.
|
11. |
Vanderschuren LJ, Niesink RJ, Spruijt BM, et al. Influence of environmental factors on social play behavior of juvenile rats. Physiol Behav, 1995, 58(1): 119-123.
|
12. |
Ma B, Xu JK, Wu WJ, et al. Survey of basic medical researchers on the awareness of animal experimental designs and reporting standards in China. PLoS One, 2017, 12(4): e0174530.
|
13. |
Schulz KF, Chalmers I, Grimes DA, et al. Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals. JAMA, 1994, 272(2): 125-128.
|
14. |
Bruguerolle B. Effect of the time of administration of a drug on its pharmacokinetics. Therapie, 1983, 38(3): 223-235.
|
15. |
Bruguerolle B, Valli M, Bouyard L, et al. Effect of the hour of administration on the pharmacokinetics of lidocaine in the rat. Eur J Drug Metab Pharmacokinet, 1983, 8(3): 233-238.
|
16. |
Marrino P, Gavish D, Shafrir E, et al. Diurnal variations of plasma lipids, tissue and plasma lipoprotein lipase, and VLDL secretion rates in the rat. A model for studies of VLDL metabolism. Biochim Biophys Acta, 1987, 920(3): 277-284.
|
17. |
Currow DC, Plummer JL, Kutner JS, et al. Analyzing phase III studies in hospice/palliative care. A solution that sits between intention-to-treat and per protocol analyses: the palliative-modified ITT analysis. J Pain Symptom Manage, 2012, 44(4): 595-603.
|
18. |
Surkont G, Wlaźlak E, Dunicz-Sokolowska A, et al. The efficacy of SUI treatment with Burch colposuspension evaluated with use of ITT analysis. Ginekol Pol, 2007, 78(5): 378-380.
|
19. |
Zhou XH, Li SM. ITT analysis of randomized encouragement design studies with missing data. Stat Med, 2006, 25(16): 2737-2761.
|
20. |
Godlee F. An international standard for disclosure of clinical trial information. BMJ, 2006, 332(7550): 1107-1108.
|
21. |
Kimball AB, Weinstock MA, Massachusetts B, et al. Mandatory registration of clinical trials: a major step forward for evidence-based medicine. J Am Acad Dermatol, 2005, 52(5): 890-892.
|
22. |
Krleza-Jerić K. Clinical trial registration: the differing views of industry, the WHO, and the Ottawa Group. PLoS Med, 2005, 2(11): e378.
|